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Abstract
Embryonic exposure to the endocrine disruptor vinclozolin during gonadal sex determination promotes an epigenetic
reprogramming of the male germ-line that is associated with transgenerational adult onset disease states. Further analysis
of this transgenerational phenotype on the brain demonstrated reproducible changes in the brain transcriptome three
generations (F3) removed from the exposure. The transgenerational alterations in the male and female brain transcriptomes
were distinct. In the males, the expression of 92 genes in the hippocampus and 276 genes in the amygdala were
transgenerationally altered. In the females, the expression of 1,301 genes in the hippocampus and 172 genes in the
amygdala were transgenerationally altered. Analysis of specific gene sets demonstrated that several brain signaling
pathways were influenced including those involved in axon guidance and long-term potentiation. An investigation of
behavior demonstrated that the vinclozolin F3 generation males had a decrease in anxiety-like behavior, while the females
had an increase in anxiety-like behavior. These observations demonstrate that an embryonic exposure to an environmental
compound appears to promote a reprogramming of brain development that correlates with transgenerational sex-specific
alterations in the brain transcriptomes and behavior. Observations are discussed in regards to environmental and
transgenerational influences on the etiology of brain disease.
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Introduction
Environment-genome interactions are critical to understanding
how health and disease are influenced by environmental
exposures. A large number of environmental factors and
compounds have been shown to influence a variety of diseases
[1], but few have been shown to promote DNA sequence
mutations [2]. In contrast, emerging evidence suggests epigenetics
(e.g. DNA methylation, RNA associated silencing and histone
modifications) is involved in the ability of environmental
experiences to regulate the genome and to develop stable
alterations in phenotype [3]. Since epigenetics can influence
genome-wide gene expression profiles (i.e. transcriptomes) of most
organs and cell types [4], environmental alterations in the
epigenome appears to be a mechanism potentially involved in
the abnormal transcriptomes associated with disease [5].
Previous observations have demonstrated that the embryonic
exposure to endocrine disrupting chemicals (i.e. vinclozolin and
methoxychlor) during gonadal sex determination induces a
transgenerational effect on adult male reproduction and sperm
production [6]. An extension of this study demonstrated that as
vinclozolin generation animals age (i.e. 6–14 months), a variety of
different disease states develop in a transgenerational manner (i.e.
F1–F4), including breast tumors, prostate disease, kidney disease
and immune abnormalities [7,8]. This transgenerational phenotype
is transmitted through the male germ-line and paternal allele [6,7].
Although females do develop disease [7,9], they do not transmit this
phenotype to the next generation [6,7]. Alterations in the male
germ-line epigenome were identified following endocrine disruptor
(i.e. vinclozolin)exposure[6].This epigenetic reprogrammingof the
male germ-line appears to allow the disease phenotype to become
transgenerational [3,6,7,8].
The biological process involved in the transgenerational disease
phenotype involves the epigenetic programming of the germ cells
during the critical period of gonadal sex determination [10,11]. As
the primordial germ cells migrate to the genital ridge and colonize
the bipotential gonad, their DNA becomes de-methylated [10,11].
The germ cell DNA is then initiated to re-methylate at the onset of
sex determination in a sex-specific manner [12]. The ability to
induce permanent alterations in the germ-line DNA methylation
pattern is hypothesized to in part allow the phenotype to become
transgenerational [3,6,7]. The influence this altered germ-line
epigenome subsequently has on the transcriptomes of developing
organs was recently shown for the testis [13] and investigated in
the current study using the brain.
Brain disorders such as autism, Rett Syndrome, Fragile X
Syndrome, and Angelman’s Syndrome appear to manifest during
postnatal neural development and involve epigenetic mechanisms.
Rett syndrome is the most common form of mental retardation in
young girls and is due to a mutation of MeCP2, a methylated
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repression [14,15,16,17]. Abnormal genomic imprinting (i.e.
parent of origin monoallelic gene expression) can promote several
inherited syndromes including Angelman’s, Prader-Willi and
Beckwith-Wiedemann Syndromes [18,19]. Fragile X Syndrome
results from the hypermethylation of the Fmr1 promoter and loss
of FMRP expression [20]. Autism has also been associated with
mutations in a methylated CpG binding protein MBD1 [21].
These previous studies suggest epigenetics has a critical role in
brain development and neural disorders.
The current study was designed to investigate the actions of the
endocrine disruptor vinclozolin on a potential transgenerational
brain phenotype. The brain transcriptome was used to assess on a
molecular level transgenerational alterations in the brain, with a
focus on the hippocampus and amygdala. Behavioral assays were
also performed to assess potential alterations in brain function.
This allows for both a molecular analysis of brain genome effects
and a behavioral analysis to demonstrate how both processes are
affected. The current observations demonstrate that the exposure
of a gestating female during gonadal sex determination to the
environmental compound vinclozolin can promote a transgenera-
tional effect on the brain, three generations removed from the
exposure, involving alterations in the brain transcriptome and
behavior.
Results
Gestating rats were exposed to a daily intraperitoneal (IP)
injection of vinclozolin during embryonic (E) day E8-E14 of
development corresponding to the period of gonadal sex
determination [6,22]. Litter mate sisters were generally used for
the control (vehicle) and vinclozolin treatments. The F1 generation
animals from different litters were bred to generate an F2
generation and then F2 generation animals bred to generate the
F3 generation. Both the control and vinclozolin generations were
bred in a similar manner, with no sibling breedings, and animals
were housed, fed and maintained under similar conditions. The F1
generation embryo and F2 generation germ-line are directly
exposed to vinclozolin, so will have direct toxicology effects [23].
Therefore, the F3 generation was selected to investigate transge-
nerational effects on the brain. The adult brains were collected for
histological analysis and RNA preparation. As previously reported,
no gross brain morphological abnormalities were observed [7]. In
addition, no alterations in serum steroid levels (i.e. progesterone,
estradiol, testosterone and corticosterone) were observed (data not
shown).
The transgenerational changes in the brain transcriptomes were
investigated with a microarray analysis of the adult (i.e. 12–15
months) hippocampus and amygdala. Differentially expressed
genes (i.e. altered genes) were identified with a statistically
significant (p,0.05) present call, a raw signal greater than 75,
and a greater than 1.5-fold change in expression between control
and vinclozolin generation brain samples. A dendrogram analysis
is shown in Figure 1 and indicates an increase (red) or decrease
(green) in gene expression between the control and vinclozolin F3
generation transcriptomes.
The transcriptomes of the amygdala and hippocampus in the
male brain demonstrated 92 genes altered in the hippocampus and
276 genes altered in the amygdala, with the majority (70%) being
decreased in expression (Figure 1). As a comparison, the F3
vinclozolin male whole brain from 6-month-old animals was
analyzed and had 778 altered genes, Supplemental Table S1.
Although the age of the whole brain used was different, the
majority (90%) of the genes altered in the male whole brain had an
increase in expression (Supplemental Table S1), suggesting
numerous brain regions are likely affected. A comparison of F3
vinclozolin generation male brain transcriptomes demonstrated
negligible overlap with each brain region (i.e. amygdala and
hippocampus) (Figure 2). Therefore, the vinclozolin F3 generation
male animals had distinct transgenerational changes in the
different brain transcriptomes (Figure 2 and Supplemental Tables
S2 and S3).
Figure 1. Brain transcriptome microarray analysis from F3 generation control (con) and vinclozolin (vin) animals. (A) Dendrogram for
male whole brain, male hippocampus and male amygdala for statistically significant regulated genes with signal above 75. (B) Dendrogram for female
hippocampus or female amygdala for statistically significant regulated genes. The scale at the bottom margin indicates an increase (red) and
decrease (green) in expression. The number of regulated genes is listed at the right of each gene set. The whole male brain was from 6 month old
animals, and amygdala and hippocampus from 12–15 month old animals.
doi:10.1371/journal.pone.0003745.g001
Epigenetic Effects
PLoS ONE | www.plosone.org 2 November 2008 | Volume 3 | Issue 11 | e3745Analysis of the transgenerational transcriptome effects in the
female hippocampus and amygdala were also assessed (Figure 1 &
2), and compared to the respective male transcriptomes.
Interestingly, the differentially expressed (i.e. altered) genes in
the hippocampus had the highest number of altered genes, 1,301
genes, with the majority (80%) being increased in expression, while
in the amygdala 172 genes were predominately decreased
(Figure 1B). The transgenerationally altered genes in the female
brain are shown in Supplemental Tables S4 and S5. The altered
genes in the female hippocampus and amygdala were distinct from
each other and from those observed in the male (Figure 2B). A
comparison of the altered genes in the female versus male
amygdala or hippocampus demonstrated that the majority of the
differentially expressed genes are region and sex-specific, (Figure 2
and Supplemental Tables S2, S3, S4 and S5).
The transgenerationally altered genes in the F3 vinclozolin male
and female generations were further analyzed. Cluster analysis of
categories of genes demonstrated that genes involved in transcrip-
tional regulation, signal transduction, and cytoskeleton were highly
represented (Figure 3 and Supplemental Tables S1, S2, S3, S4 and
S5). Other gene categories represented included those involved in
metabolism, cell cycle, development, proteolysis and apoptosis. A
mixture of up-regulated and down-regulated genes are represented
in all microarray analysis (Figures 1 & 3). In addition to the full lists
and categories of transgenerationally altered genes, the subsets of
altered genes similar within the male and female amygdala and
hippocampus are bolded in the respective Supplemental Tables
S2, S3, S4 and S5. The genes similar between amygdala and
hippocampus for the same sex are italicized (Tables S2, S3, S4 and
S5).
Analysis of specific cellular processes and pathways within the
different transgenerationally altered gene sets is shown in Table 1.
The pathways containing the highest numbers of affected genes
are listed. One pathway, mitogen-activated protein kinase
(MAPK) signaling pathway, was affected in all of the altered gene
sets. An illustration of the affected MAPK signaling pathway for
the female hippocampus is presented in Supplemental Figure S1.
A number of neural-pathway or neuro-processes were also
affected. One commonly affected pathway was the Neuroactive
Ligand-Receptor Interaction pathway. Other neural-pathways
affected include axon guidance, long-term potentiation, olfactory
transduction, gonadotropin releasing hormone (GnRH) signaling,
melanogenesis and long-term depression. An illustration of the
neuroactive ligand-receptor interaction pathway affected in the
female hipppocampus is presented in Supplemental Figures S2.
The female hippocampus was selected for the pathway examined
in Figures S1 and S2 due to having the largest numbers of altered
genes, but those genes altered in the other tissues are identified in
the Figure S1 and S2 legends. Although some similarities exist, the
group of affected pathways/processes within each gene set is
distinct. Those pathways distinct to a specific brain region are
indicated in bold in Table 1.
To investigate important brain genes relevant to behavior and
brain disease (e.g. schizophrenia), and to confirm the microarray
analysis, a quantitative real-time PCR procedure was used to
determine the expression of genes listed in Table 2, (e.g. examine
catechol-o-methyltransferase (Comt) expression). The hippocam-
pus and amygdala from control and vinclozolin F3 generation rats
were collected, RNA isolated and analyzed. The ratio of gene
expression between vinclozolin and control (V/C) samples is
Figure 2. Comparison of the F3 generation regulated gene sets (i.e. transcriptomes). Venn diagram with total regulated (.1.5 fold-change
between control and vinclozolin) genes listed and the overlap, (A) brain nucleus differences within a sex; (B) sex differences within a brain nucleus.
doi:10.1371/journal.pone.0003745.g002
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The analysis showed the same trends in expression for the majority
of the genes with microarray or QPCR observations (Table 2),
with slight changes in the magnitude of the effects. One gene
Grik2 was found to be annotated incorrectly on the microarray
chip using non-coding sequence oligonucleotides, so the QPCR
procedure is accurate for this gene and not the microarray. For
Vof16 female hippocampus the microarray had a greater than 10-
fold increase, but for the QPCR a decrease. Further analysis
demonstrated the control signal in the microarray was artificially
low due to inaccurate normalization from the mismatch
oligonucleotides. The Drd2 gene expression in male amygdala in
the microarray had a decrease, while the QPCR had an increase,
Table 2. The signal for the microarray was at the low limit of
detection which may contribute to the difference. Therefore, the
quantitative PCR procedure confirmed the majority of the
microarray analysis, for the genes investigated that had brain
disease relevance discussed below, but some differences were
observed for various technical reasons.
A correlation of several transgenerationally affected genes
previously shown to be involved in brain disease or neurological
disorders is shown in Table 2. We focused on genes identified by
two or more studies in the literature as being likely candidate genes
involved in mental disorders. The Comt gene [24,25,26]
microarray data for male and female amygdala and hippocampus
are presented. The S100 (calcium binding protein A4) [28] gene
expression was increased in the male amygdala. The male
amygdala and female hippocampus showed an increase in
expression in brain derived neurotropic factor (BDNF) and the
male amygdala had an increase in D2 dopamine receptor (DRD2)
expression. There is an increase in the expression of ischemia-
related factor Vof16 [28] in the male and female hippocampus.
Finally, there is an increase in expression in the female amygdala
of the glutamate receptor (Grik2), as determined with QPCR.
Therefore, a number of genes previously shown to be involved in
brain abnormalities and behavior were found to be transgener-
ationally altered, Table 2.
Experiments were initiated to extend the molecular analysis to a
more behavioral level. Behavioral analyses of the control and
vinclozolin F3 generation male and female animals were
performed (Figure 4). A light:dark box procedure and an elevated
plus-maze procedure was used to measure anxiety-like behaviors
and general motor activity. Both young postnatal (P) day 70–155
(P70–155) and aged postnatal (P.200) rats were used in the
analysis. In brief, there was a significant effect of sex on latency to
enter dark, time on the light side, and transitions for young rats
and a significant effect of sex on latency to enter dark for old rats.
Previously, we demonstrated that vinclozolin F3 generation
Figure 3. Categorization of genes into functionally related gene groups with the number of genes up-regulated or down-regulated.
(A) male hippocampus regulated gene list; (B) male amygdala regulated gene list; (C) female hippocampus regulated gene list; and (D) female
amygdala regulated gene list.
doi:10.1371/journal.pone.0003745.g003
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different adult onset diseases [7]. Therefore, the young P70-155
animals were selected for behavioral studies to avoid any disease
artifacts. However, the aged (P.200) animals were also used for
comparison with the younger animal behaviors and to better
correlate with the microarray analysis. Supplemental Table S6
summarizes the performance in the light:dark box under low
lighting conditions for female and male young and aged rats. In
general, this condition did not appear to produce the high anxiety-
like states that were found under the higher lighting conditions,
based on the time spent in the light compartment.
In regards to alterations in female behavior, Figure 4A–F shows
the results from young and aged female rats tested in the light:dark
box under high lighting conditions and in the elevated plus-maze.
There were no differences between control and vinclozolin
generation rats in the latency to enter the dark compartment,
time spent on the light side of the box, or in the number of
transitions made between the light or dark sides of the box. In aged
female rats there was a tendency for vinclozolin generation rats to
show a decreased latency to enter the dark side and a significant
decrease in time spent in the light side of the box, with no
differences in the number of transitions (Figure 4A–C). The
elevated plus-maze results from young and aged females are shown
in Figure 4D–F. In both age groups, vinclozolin generation rats
demonstrated a decrease in both the percent time spent on the
open arms and in the percent of open arm entries, with no
difference in the number of total arm entries.
With respect to alterations in male behaviors, Figure 4G–L
shows the response from young and aged males in the light:dark
box under high lighting conditions and young males in the
elevated plus maze. Young males demonstrated no difference in
the latency to enter the dark side of the box, but vinclozolin
generation males demonstrated a significant increase in the time
spent on the light side of the box and in the number of transitions
between the light and dark sides of the box. No differences
between control and vinclozolin generation rats were found in the
aged males. Figure 4J–L demonstrates the performance of young
males on the elevated plus-maze. No differences between control
and vinclozolin generation rats were present for percent open arm
time or percent of open arm entries. However, there was a
significant increase in the number of total arm entries in
vinclozolin generation rats. Aged males were not run on the
elevated plus-maze task because they were too large for the
dimensions of the apparatus.
Discussion
The current study was designed to investigate the transgenera-
tional actions of vinclozolin on the brain transcriptome and
behavior. The objective was to provide both molecular and
behavioral evidence for any transgenerational effects. Previously,
transgenerational effects were observed on mate preference
behavior in the F3 generation vinclozolin animals [29], with
females from either control or vinclozolin F3 generation having a
mate preference for control generation males and not vinclozolin
generation males. Due to this effect on behavior, the current study
extends this analysis to investigate the transgenerational effects of
vinclozolin on the brain transcriptome and anxiety-like behavior.
Therefore, the previous study (29) focused on mate preference and
evolutionary biology while the current study investigates molecular
effects on the brain and disease associated behaviors. Although no
major morphological effects were observed between the control
and vinclozolin generation animals, significant transgenerational
alterations were observed in the brain transcriptomes. Minimal
overlap was observed between the genes altered in the hippocam-
pus and amygdala. This finding suggests the epigenetic program-
ming of the different brain regions are distinct, such that the
eventual effect on the various transcriptomes are unique.
Interestingly, the F3 generation male and female hippocampus
and amygdala had transgenerational transcriptomes unique from
each other. The current observations demonstrate that vinclozolin
promotes a sex-specific transgenerational programming of the
brain transcriptomes.
Analysis of the transgenerationally altered genes demonstrated a
number of cellular processes and signal pathways being affected.
Although each brain region was distinct in the individual gene set
affected, a number of processes and pathways were similar
(Table 1). For example, the mitogen activation pathway kinase
(MAPK) signaling pathway that is responsive to a large number of
regulatory growth and differentiation factors was common to all
the altered transgenerational transcriptomes. Interestingly, a
Table 1. Pathways/processes (KEGG) with the greatest
number of affected genes along with any neural-pathway/
processes (*) with multiple altered genes.
Altered Cellular Process/Pathway
Number Altered
Genes Score
Male Amygdala
MAPK Signaling Pathway 6 1.68
Wnt/Calcium Signaling Pathways 6/4 4.0/1.17
*Neuroactive Ligand-Receptor Interactions 4 0.2
*Glioma 3 2.6
*Long-Term Potentiation 3 2.3
*Olfactory Transduction 3 5.05
Male Hippocampus
Colerectal Cancer 2 2.53
Cytokine Receptor Interactions 2 1.65
Jak-Stat Signaling Pathway 2 2.03
MAPK Signaling Pathway 2 0.61
*Neuroactive Ligand-Receptor Interactions 2 0.4
Female Amygdala
Antigen Processing and Presentation 2 3.35
Cell Adhesion Molecules (CAMs) 2 1.81
Colorectal Cancer 2 2.43
MAPK Signaling Pathway 2 0.64
Nitrogen Metabolism 2 6.46
Female Hippocampus
MAPK Signaling Pathway 25 3.21
Focal Adhesion 19 3.02
Wnt Signaling Pathway 19 4.9
*Axon Guidance 16 3.97
*Neuroactive Ligand-Receptor Interaction 13 21.06
*Long-Term Potentiation 11 3.87
*GnRH Signaling Pathway 10 2.29
*Melanogenesis 10 2.43
*Long-Term Depression 7 1.21
The statistical score (Score) is from a hypergeometric test with the larger the
value from 0.0 (either + or 2) being more significant. The bolded pathways are
those specific to a brain region compared to the others.
doi:10.1371/journal.pone.0003745.t001
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with most transgenerational gene sets. These include melanogen-
esis, axon guidance and long-term potentiation (Table 1). A
process affected in most of the altered transgenerational
transcriptomes was the neuroactive ligand-receptor interaction
process. Although correlation of pathways or genes with specified
brain functions cannot be made, observations suggest transgenera-
tional reprogramming of the brain transcriptome may alter
behavior. Therefore, behavior studies were performed on the
control and vinclozolin F3 generation animals, with a focus on
anxiety-like behaviors due to the alterations in the amygdala
transcriptomes. Although anxiety behaviors were the focus, the
whole brain transcriptome data suggests other behavioral indices
may also be influenced.
Findings revealed that vinclozolin generation female rats
demonstrated an increase in anxiety-like behaviors. In the females
from the vinclozolin generation lineage, both young and aged
female rats showed significant decreases in percent open arm time
and percent open arm entries, without an alteration in general
activity level on the elevated plus-maze. In aged females, these
findings were consistent with the results from the light:dark box, in
which there was a decrease in time spent on the light side of the
box. Young females did not demonstrate differences between
control and treated rats, suggesting that the light:dark task may be
less sensitive or that a different component of anxiety-like behavior
is assessed in the elevated plus-maze.
In contrast to females, male rats showed decreased anxiety-like
behavior in the light:dark box. In both the light:dark box and
elevated plus-maze, treated young males showed hyperactivity that
may be related to increased exploration, high sensation-seeking
behavior, and/or increased impulsivity. An example of such
behavior is an enhanced susceptibility to acquire self-administra-
tion of the abused drug, amphetamine [30]. Aged males were
generally less active than younger males when tested in the
light:dark box, and this difference was significant under low-
lighting conditions. The decreased activity in these aged rats may
be normal and partially explained by the previous observation that
aged males greater than 6 months develop various diseases such as
prostate disease, kidney disease, immune abnormalities and tumor
development [7]. Younger animals less than six months old do not
develop disease other than spermatogenic cell defects [6,7].
Therefore, the younger animal behavioral analysis is not
influenced by disease, but behavior in the older animals needs to
be considered in regards to their potential disease states. The
behavior analysis was performed on both younger and older
animals for comparison and the older animal age better correlated
with the microarray analysis.
The mechanisms mediating the sex differences in anxiety-like
behavior in vinclozolin generation females and males remain
unknown. Hormones and metabolites of progesterone and
testosterone have been shown to alter anxiety-like behaviors
[31,32,33,34]. Previously we reported the F3 generation vinclo-
zolin animals had no major effects on hormone levels [6,7], and
steroid levels for progesterone, estradiol, testosterone and
corticosterone were not affected in the current study, (data not
shown). Therefore, altered endocrinology does not appear to be a
factor in the altered anxiety behaviors observed. The anxiety-like
behavior assessed will likely involve multiple causal factors. For
example, one factor that could cause alterations in the anxiety-like
behavior is that, since the F2 germ line was directly exposed to
vinclozolin, these F2 generation rats may rear F3 pups differently
from control F2 rats, potentially leading to altered anxiety in adult
F3 rats. For this reason, caution should be used in the mechanistic
interpretation of the behavioral studies. For this reason we have
referred to the behaviors observed as anxiety-like and caution
should be used in interpretation of the behavioral studies.
The analysis of the brain transcriptomes demonstrated that a
number of genes previously shown to be involved in brain disease
or neurological disorders were transgenerationally altered
(Table 2). For example, the catechol-o-methyltransferase (Comt)
gene is expressed in the brain and associated with the etiology of
schizophrenia and depression [25,26,27]. The serotonin trans-
porter (SLLGA4) gene is important for brain function and linked
to abnormalities such as autism [28]. The S100 calcium binding
protein A4 gene has been shown to be involved in developmental
stress responses [29]. The altered expression of brain derived
neurotrophic factor (BDNF) and the D2 dopamine receptor
(DRD2) is significant as the former has been implicated in
Alzheimer’s disease, affective disorders, posttraumatic stress
disorder, schizophrenia, and substance dependence [35], while
Table 2. Genes related to mental health disorders that show a significant (in bold) alteration in expression in Vinclozolin-lineage
rats.
Gene Area Cont Vincl V/C Alteration QPCR V/C
Comt (catechol-O-methyltransferase) Male Amygdala 293 182 0.62 Decrease 0.01
Female Amygdala 265 238 0.9 Decrease 0.21
Male Hippocampus 324 149 0.46 Decrease 0.60
Female Hippocampus 206 250 1.21 Increase 1.60
Grik2 (Glutamate receptor, ionotropic) Female Amygdala 4 39 9.84 Increase 5.62
S100a4 (Calcium binding rpotein A4) Male Amygdala 84 119 1.41 Increase 1.28
Bdnf (brain derived neurotropic factor) Male Amygdala 72 113 1.58 Increase 1.26
Female Hippocampus 137 236 1.72 Increase 4.23
Drd2 (D2 dopamine receptor) Male Amygdala 65 37 0.56 Decrease 2.28
Vofl6 (Ischemia-related factor) Male Hippocampus 43 95 2.21 Increase 2,09
Female Hippocampus 7 122 18 Decrease 0.88
Listed are raw microarray signals, with V/C indicating the ratio of the signals. Although several of the V/C ratios are less than 1.5-fold changed, they are presented to
allow comparison with the quantitative PCR (QPCR) results. The Real-time QPCR for the genes indicated regarding the vinclozolin/control (V/C) ratio is presented. All the
microarray and QPCR ratios in bold were statistically significantly different (P,0.05) between control and vinclozolin values.
doi:10.1371/journal.pone.0003745.t002
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PLoS ONE | www.plosone.org 6 November 2008 | Volume 3 | Issue 11 | e3745Figure 4. Performance in the light:dark box in young and aged third-generation female and male rats. Data are mean6SEM of latency to
enter dark (A, G), time spent in the light side of the box (B, H) and the total number of transitions made between the light and dark sides of the box (C, I)
in young (left panel) andaged(rightpanel)control andvinclozolin generationrats. Foryoungandaged female rats N=8–9/group.For B aged:t15=2.65,
p,0.018. * P,0.05, compared with control. Performance in the elevated plus-maze in young and aged third-generation female and male rats. Data are
mean6SEMofpercentopenarmtime(D,J),percentopenarmentries(E,K)andtotalentries(F,L)inyoung(leftpanel)andaged(rightpanel)controland
vinclozolingenerationrats. For youngrats, allanimalsfrom aboveareshown; foragedrats, N=5 (control) and7 (vinclozolin). Theaged grouprepresents
a subset of those run in the light:dark box shown because of technical (unstable lighting) conditions during testing for the first 5 rats; these rats were
omitted from the analysis. For D young: t15=2.30, p,0.036. For E young: t15=2.51, p,0.024. For D aged: t10=2.40, p,0.037. For E aged: t10=2.82,
p,0.018. *P,0.05,comparedwith control. For youngmale rats, N=9–12/group. Foraged malerats, N=9–10/group. ForHyoung:t19=22.65,p,0.016.
For I young: t19=22.46, p,0.024. * P,0.05, compared with control. All young male animals L: t19=23.32, p,0.004. *P,0.05, compared with control.
doi:10.1371/journal.pone.0003745.g004
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(PTSD), anxiety, social dysfunction, and depression [36]. Potential
altered epigenetic regulation of the ischemic-related factor Vof16
gene is also associated with stress responses [29]. Therefore, a
number of genes previously shown to be involved in brain
abnormalities and behavior were found to be transgenerationally
altered. Although causal relationships cannot be made in the
current study, the role of specific transgenerationally altered genes
can be investigated in the future.
Endocrine disruptors are a class of compounds that alter
hormone actions and endocrinology [8,37,38]. Many environ-
mental compounds from fungicides to plastics have endocrine
disruptor activity [38,39]. The endocrine disruptor used in the
current study was vinclozolin, which is a fungicide used in the fruit
industry [38]. Vinclozolin and its metabolites are anti-androgenic
compounds that bind and alter androgen receptor actions [40].
Embryonic and early postnatal exposure to vinclozolin [22,38,40]
or other endocrine disruptor compounds promote adult onset
disease in numerous species [1,6,37,39,41]. The frequency of
transgenerational disease induction and reproducibility of the
phenomena [6,7] suggests an epigenetic mechanism is involved.
In the context of the current study, two potential epigenetic sites
of action for environmental toxicants need to be considered. The
first is during the active development of a specific organ when the
epigenome and transcriptome is undergoing a cascade of
developmental stages to eventually establish the adult organ
transcriptome and physiology. In the event a factor reprogrammed
or altered an epigenetically labile site or metastable allele of the
epigenome during this development, the adult organ may not have
the proper transcriptome and become susceptible to develop
disease. This epigenetically induced adult onset disease state would
not be passed to subsequent generations, but may be a significant
factor in disease etiology [3,42]. In regards to behavior this has
been termed a context-dependent epigenetic modification [43].
The second major epigenetic site of action involves reprogram-
ming the epigenome of the germ-line [3,6,8]. The embryonic
programming of the genome during gonadal differentiation could
be modified to promote an abnormal epigenome. In the event this
modified epigenetic program (i.e. DNA methylation) became
imprinted-like, then all subsequent generation programming
would be influenced [3]. The primordial germ cells undergo a
de-methylation prior to gonadal development and then re-
methylation in a sex-specific manner during sex determination
[10,11,12]. The germ cells at this time of development appear to
be sensitive to epigenetic re-programming [6,7,8]. Observations
demonstrate that the endocrine disruptor vinclozolin can alter the
epigenome of the male germ-line transgenerationally. The ability
of this altered epigenome to promote a transgenerational
epigenetic alteration in the transcriptome has been shown in the
developing testis [13] and is speculated to be the mechanism
behind the subsequent development of heritable adult onset
disease [3,6]. The role of epigenetic alterations in the brain cell
populations as a causal factor in the transcriptome and behavior
alterations remains to be elucidated in future studies.
The combined current observations indicate that vinclozolin
exposure of a gestating female rat during gonadal sex determina-
tion can promote a transgenerational alteration in the brain
transcriptome and behavior. We suggest this is due to an
epigenetic alteration in the male germ-line that transgenerationally
transmits, through an altered germ-line epigenome, an altered
epigenetic reprogramming of the brain. The transgenerational
changes in different regions of the brain (i.e. hippocampus and
amygdala) are distinct and sex specific. These molecular changes
in the brain transcriptome are associated with altered behavior,
but the causal relationships remain to be established. Interestingly,
the alterations in male and female behavior are different, with
females developing an increase in anxiety-like behavior and males
a decrease in anxiety-like behavior and an increase in activity.
Therefore, an environmental compound (i.e. endocrine disruptor)
exposure during pregnancy promoted a transgenerational alter-
ation in brain programming and behavior. The observations
suggest some element of neurodegenerative disease and brain
abnormalities may be induced through an epigenetic transgenera-
tional mechanism. The component of brain abnormalities that are
transgenerational remains to be determined, but some neurode-
generative conditions and abnormalities are familial and have a
paternal heritability. Future studies will need to determine the role
of transgenerational epigenetic mechanisms in brain development,
physiology and disease.
Materials and Methods
A. Animals & In Vivo Procedures
Gestating outbred Sprague-Dawley mother rats from timed
pregnant colonies housed at the Washington State University
Vivarium were given intraperitoneal (IP) injections of vinclozolin
(100mg/kg/day) from embryonic day 8–14 (E8–E14) of gestation
(i.e. F0 generation) as previously described [44]. Sperm positive
vaginal smear date was identified as embryonic day 0. Gestating
control mothers (i.e. F0 generation) received vehicle alone (i.e.
sesame oil and DMSO). At least 8 lines (individual F0 injected
females) were generated for controls and 8 lines for vinclozolin
generations for these analyses. The F1–F3 generation animals
derived from a vinclozolin exposed F0 mother are referred to as
vinclozolin generation animals, while those from control F0
generation mothers are identified as control generation animals.
The brains from males were collected at 12 months of age and
females at 15 months of age for analysis of the hippocampus and
amygdala. Adult F1 vinclozolin generation (offspring from F0
mothers) males were bred to F1 vinclozolin generation females to
generate the F2 vinclozolin generation. Adult F2 vinclozolin
generation males were bred to F2 vinclozolin generation females
to generate the F3 vinclozolin generation. Rats for the control
groups (i.e. generations F1–F3) were bred in the same manner for
all the generations. No inbreeding or sibling crosses were
generated. All animals were housed in the same room with similar
lighting and feeding conditions. All procedures have been
approved by the Washington State University Animal Use and
Care Committee. The hormone assays were performed by the
Assay Core Laboratory of the Center for Reproductive Biology at
Washington State University. These assays were radioimmunoas-
says for corticosterone, progesterone, testosterone and estradiol.
Serum was collected from the same animals used in the microarray
analyses for hormone assays. No differences were observed
between control and vinclozolin F3 generation animals in steroid
levels, (data not shown).
B. Brain Collection and Histology
The brain was removed in less than 1 minute and placed in
crushed ice to chill. The brain was then cut in half along the
midline. The hippocampus and amygdaloid nuclei were dissected
from on side of each brain using a chilled brain mold and specific
brain areas were dissected using coordinates from Paxinos and
Watson (Hippocampus: Bregma 22.12 to 24.52; Amygdala
Bregma: 22.30 to 23.60) within 3–5 min [45]. Tissue was placed
in chilled TRIZOL (150 ml) in 1.5 ml eppendorfs tubes according
to the manufacturers specifications. After all brains were dissected,
the eppendorfs tubes were vortexed (15 sec) and then frozen on
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St. Louis, MO) for 1 hour, embedded in paraffin and sectioned.
Sections were stained with hematoxylin and eosin according to
standard procedures. The Center for Reproductive Biology,
Histology Core Laboratory assisted with these procedures. The
animal numbers were n=6 for vinclozolin and n=6 for controls
from 3 different lines (i.e. F0 injected mothers) for the F3
generation.
C. Microarray Analysis and Bioinformatics
The Genomics Core in the Center for Reproductive Biology at
Washington State University performed the microarray analysis as
previously described [46,47]. Briefly, RNA from control and
vinclozolin F3 generation adult male whole brain or male and
female hippocampus or amygdala was reverse transcribed into
cDNA and cDNA was transcribed into biotin labeled RNA. Biotin
labeled RNA was then hybridized to the Affymetrix rat R230 2.0
gene chips (Affymetrix, Santa Clara, California). Biotinylated
RNA was then visualized by labeling with phycoerythrin-coupled
avidin. The microarray chip was scanned on an Affymetrix Gene
Chip Scanner 3000 (Affymetrix, Santa Clara, CA). The micro-
array image data were converted to numerical data with
GeneChip Operating Software (GCOS version 1.2.1.001; Affy-
metrix) using a probe set target signal of 125. An analysis was
performed with GCOS to assess the relative abundance of the
transcripts based on signal and detection calls (present, absent or
marginal). This information was imported into Genespring
software (Silicon Genetics, Redwood City, CA) and normalized
using the recommended defaults. This includes setting signal
values below 0.01 to a value of 0.01, total chip normalization to
the 50
th percentile, and normalization of each chip to the median.
Unless otherwise indicated, in order for a transcript to be
considered present it had to be both present in the GCOS
present/absent call, and have an expression level greater than 75.
Briefly, the signals from 11 perfect matched oligonucleotides for a
specific gene and 11 mis-matched oligonucleotides were used to
make comparisons of signals to statistically determine a present call
using a one-sided Wilcoxian’s signed rank test. In order for a
transcript to be considered changed it had to exhibit at least a 1.5-
fold change between the means of the control and vinclozolin
samples and have a Students 1-tail t-test p#0.05 between samples.
The raw signal cut off was 75. Therefore, the data presented are
for genes that were determined to be statistically present and found
to have a statistically significant difference between control and
vinclozolin samples.
Two different experiments were performed involving two
different sets of animals, RNA sample preparations and micro-
array chips. Therefore, two control and two vinclozolin generation
samples were analyzed on four different chips. This allowed a 2X2
factorial comparison with all present/absent calls and changes in
expression to be statistically significant for further analysis. The R
2
for the replicate microarray chips was found to be R
2.0.98, which
indicated negligible total variability between replicates. This R
2
value and statistical analysis indicated that the chip number used
was appropriate. The number of chips required for specific
experiments has been previously reviewed [48] and 2 biological
replicate chips were determined to be statistically appropriate.
Previous studies have demonstrated that microarray data are
validated with quantative PCR data [47,49]. Due to the presence
of 11 different oligonucleotide sets for each specific gene being
used on the microarray versus only a single primer set for a gene in
a quantative PCR, the microarray is more effective at eliminating
false positive or negative data and provides a more robust
quantitation of changes in gene expression. However, validation of
microarray data was performed with six selected genes using a
quantitative real-time PCR procedure. Although the magnitude of
the change can vary, the absence or presence of a change is generally
consistent, Table 2. A brain related genes COMT, Grik 2, S100a4,
B d n f ,D r d 2a n dV o l 1 6w e r es e l e c t e dt op e r f o r mq u a n t i t a t i v eP C R
analyses to confirm the microarray data. The primer sets used for the
Comt were forward: 59-GAGATCTTCACGGGGTTTCA-39 re-
verse: 59-AGATGTGGTGTGAGCTGCTG-39;f o rG r i k2f o r w a r -
d:59ACAGTTCATCAGCCAATGCTGTGC-39 reverse 59AAC-
TGCACCAAATCCAAGATGGCG-39; for S100a4 forward
59ATACTCAGGCAACGAGGGTGACAA-39 reverse 59TCATG-
GCAATGCAGGACAGGAAGA-39; for Bdnf forward 59AGA-
AGGTTCGGCCCAACGAAGAAA-39 reverse 59AGAAAGAG-
CAGAGGAGGCTCCAAA-39;f o rD r d 2f o r w a r d5 9TGACA-
GTCCTGCCAAACCAGAGAA-39 reverse 59CACACCGAGAA-
CAATGGCAAGCAT-39; and Vol16 forward 59TCGGAGCG-
TAATACCAACAGCTCA-39 reverse 59ACACGTGTAGACAA-
TGCAGAGGGA-39. The primer sets used for the constitutively
expressed S2 gene were (S2, forward 59- GCTCGTGGAGG-
TAAAGCTGA-39, and reverse 59- TGAGACGAACCAGCACA-
GAG-39).SimilarobservationsweremadewiththisquantitativePCR
procedure and the microarray analysis, Table 2.
D. Behavioral Analysis
Animals were housed under a 12:12 hr light:dark cycle (lights on
at 07:00am) with food and water available ad libitum. Females
designated as ‘‘young’’ were between postnatal day (P) 93-124 and,
and males designated as ‘‘young’’ were between P82-155. Females
designated as ‘‘aged’’ were between P369-386 and males
designated as ‘‘aged’’ were between P202-385, with one rat tested
at P527. The total number of animals analyzed is listed in the
figure legend.
The light:dark box consisted of Plexiglas that was a total of
106 cm in length, 22 cm in width and 25 cm in height. Clear
Plexiglas comprised 72 cm of the length and black Plexiglas
comprised 34 cm of the total length. The clear portion had a clear
floor and a white Plexiglas lid, and the black portion had a black
floor and a black Plexiglas lid. A light (23 W) was placed 11 cm
over the center of the white lid.
The elevated plus-maze was as previously described [50] and
consisted of a ‘‘plus’’-shaped platform made of black opaque
Plexiglas, which was 10 cm in width and 50 cm in length, creating
a1 0 610 cm neutral zone in the center. The plus-maze was
elevated 50 cm from the floor. Two of the arms were enclosed
with black Plexiglas walls 40 cm high, with no ceiling.
F3 generational male and female Sprague-Dawley rats from
control and vinclozolin lineages were used in a blinded procedure
for the behavioral studies. All behavioral experiments were carried
out during the first 5 hr of the light cycle, and the same rats were
always tested the same time of day. The light:dark box has been
used to assess the level of anxiety-like behavior in rodents. It is
based on the natural aversion to bright light and open spaces
[51,52], and it has been used to model anxiety. Decreased latency
to enter the dark side of the box and more time spent in the dark
side are believed to signify increased anxiety levels, and
pharmacological studies validate these behaviors as measures of
increased anxiety. For the light:dark box, rats were placed
individually into the light side of the compartment at the end
opposite from the dark compartment, facing the dark compart-
ment. The latency to enter the dark compartment, time spent in
the light side of the compartment and number of transitions made
between the light and dark compartments were recorded for
5 min. The rat was considered to be in a compartment only when
all four paws were located in that compartment. Animals were first
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additional lighting). One day to one week later, rats were again
tested in the light:dark box exactly as described above except that
additional lighting overhead was present to provide a second
‘‘dose’’ of conditions that might reveal differences between groups
on anxiety-related behavior compared with when no overhead
light was present. The light (described above) was placed on the
white lid above the center of the light compartment. One week
after testing in the light:dark box in which the additional lighting
was used, all rats were tested in the elevated plus-maze as
previously described [50]. The elevated plus-maze relies on the
animal’s natural fear of open spaces, and the percent time spent on
the open arms and percent of open arm entries are believed to be a
measure of general anxiety level [53]. For this task, rats were
placed individually into the center (neutral) zone of the maze,
facing an open arm. Rats were allowed to explore for a 5 min
period, and the number of open and closed arm entries and time
spent on the open and closed arms were recorded. Animals were
considered to be in the open or closed arms only when all four
paws crossed out of the neutral zone. Percent open arm time was
calculated by taking the time spent in the open arms and dividing
it by the sum of the time spent in the open arms plus time spent in
the closed arms. The percent of open arm entries was calculated
by taking the number of open arm entries and dividing it by the
sum of the number of open arm plus closed arm entries.
E. Statistical Analysis
The non-behavioral data were analyzed using a SAS program.
The values were expressed as the mean6SEM. Statistical analysis
was performed and the difference between the means of control
and vinclozolin samples or animals were determined using a
Student’s t-test. In vivo experiments were repeated with 3–6
individuals for each data point. A statistically significant difference
was confirmed at p#0.05. A two-way ANOVA was used to
analyze the effect of sex and treatment (control or vinclozolin) on
each of the five behaviors measured on young rats and each of the
three behaviors measured on both sexes of old rats. Young and old
rats were analyzed separately. Before doing ANOVA, the data was
tested for normality and log-transformed if necessary to normalize
it. When the ANOVA reported no interaction between sex and
treatment, the ANOVA re-calculated to test for the effect of sex
and the effect of treatment but not their interaction. Subsequent
analysis was conducted separately for each sex and each age by
comparing between control and vinclozolin generation rats using a
two-tailed, unpaired t-test. Statistical significance was considered if
p#0.05. All statistical differences are reported in the figure
legends.
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